Department of Obstetrics and Gynecology, Suzhou Wuzhong People's Hospital, Jiangsu Province, No. 61, Dongwu North Road, Suzhou City, 215128, China.
J Cancer Res Clin Oncol. 2024 Jun 6;150(6):294. doi: 10.1007/s00432-024-05799-y.
Cervical cancer (CC) is a common malignancy amongst women globally. Ubiquitination plays a dual role in the occurrence and development of cancers. This study analyzed the mechanism of long noncoding RNA HOXC cluster antisense RNA 3 (lncRNA HOXC-AS3) in malignant proliferation of CC cells via mediating ubiquitination of lysine demethylase 5B (KDM5B/JARID1B).
The expression patterns of lncRNA HOXC-AS3 and KDM5B were measured by real-time quantitative polymerase chain reaction or Western blot analysis. After transfection with lncRNA HOXC-AS3 siRNA and pcDNA3.1-KDM5B, proliferation of CC cells was assessed by the cell counting kit-8, colony formation, and 5-Ethynyl-2'-deoxyuridine staining assays. The xenograft tumor model was established to confirm the impact of lncRNA HOXC-AS3 on CC cell proliferation in vivo by measuring tumor size and weight and the immunohistochemistry assay. The subcellular location of lncRNA HOXC-AS3 and the binding of lncRNA HOXC-AS3 to KDM5B were analyzed. After treatment of lncRNA HOXC-AS3 siRNA or MG132, the protein and ubiquitination levels of KDM5B were determined. Thereafter, the interaction and the subcellular co-location of tripartite motif-containing 37 (TRIM37) and KDM5B were analyzed by the co-immunoprecipitation and immunofluorescence assays.
LncRNA HOXC-AS3 and KDM5B were upregulated in CC tissues and cells. Depletion of lncRNA HOXC-AS3 repressed CC cell proliferation and in vivo tumor growth. Mechanically, lncRNA HOXC-AS3 located in the nucleus directly bound to KDM5B, inhibited TRIM37-mediated ubiquitination of KDM5B, and upregulated the protein levels of KDM5B. KDM5B overexpression attenuated the inhibitory role of silencing lncRNA HOXC-AS3 in CC cell proliferation in vivo and in vitro.
Nucleus-located lncRNA HOXC-AS3 facilitated malignant proliferation of CC cells via stabilization of KDM5B protein levels.
宫颈癌(CC)是全球女性中常见的恶性肿瘤。泛素化在癌症的发生和发展中起着双重作用。本研究通过介导赖氨酸去甲基酶 5B(KDM5B/JARID1B)的泛素化来分析长非编码 RNA HOXC 簇反义 RNA 3(lncRNA HOXC-AS3)在 CC 细胞恶性增殖中的机制。
实时定量聚合酶链反应或 Western blot 分析检测 lncRNA HOXC-AS3 和 KDM5B 的表达模式。转染 lncRNA HOXC-AS3 siRNA 和 pcDNA3.1-KDM5B 后,通过细胞计数试剂盒-8、集落形成和 5-乙炔基-2'-脱氧尿苷染色测定 CC 细胞的增殖。通过测量肿瘤大小和重量以及免疫组织化学测定,建立异种移植肿瘤模型,以体内验证 lncRNA HOXC-AS3 对 CC 细胞增殖的影响。分析 lncRNA HOXC-AS3 的亚细胞定位和 lncRNA HOXC-AS3 与 KDM5B 的结合。用 lncRNA HOXC-AS3 siRNA 或 MG132 处理后,测定 KDM5B 的蛋白和泛素化水平。此后,通过 co-immunoprecipitation 和免疫荧光测定分析三肽重复含 37 (TRIM37)和 KDM5B 的相互作用和亚细胞共定位。
lncRNA HOXC-AS3 和 KDM5B 在 CC 组织和细胞中上调。沉默 lncRNA HOXC-AS3 抑制 CC 细胞增殖和体内肿瘤生长。机制上,lncRNA HOXC-AS3 位于细胞核内,直接与 KDM5B 结合,抑制 TRIM37 介导的 KDM5B 泛素化,上调 KDM5B 蛋白水平。KDM5B 过表达减弱了沉默 lncRNA HOXC-AS3 对 CC 细胞体内和体外增殖的抑制作用。
位于核内的 lncRNA HOXC-AS3 通过稳定 KDM5B 蛋白水平促进 CC 细胞的恶性增殖。